Equifax (EFX) Tests Its Valuation As New Fraud Tools Expand Its Verification Push
Equifax’s new fraud tools and what they might mean for the stock
Equifax (EFX) just rolled out three fraud focused products, including Signal Score for Email, Signal Score for Device, and Healthcare Report Credential ID, signaling a push deeper into verification and digital risk management.
These launches land at a tricky moment for Equifax shareholders, with the share price down about 22% over the past month and roughly 30% year to date, while the 1 year total shareholder return has declined about 40%. This points to fading momentum despite ongoing product development.
Scan how Equifax’s fraud push compares with peers by reviewing the 30 resilient stocks with low risk scores, which aims to balance digital risk exposure with sturdier business fundamentals.
Equifax now trades at a steep discount to both analyst targets and some intrinsic value estimates after that sharp slide. Is the market prudently pricing in risk, or has caution pushed the stock too far?
Most Popular Narrative: 31% Undervalued
On the most followed view of Equifax, a fair value of $214.95 sits well above the last close at $148.80. This frames the recent selloff very differently from the price chart alone.
Rapidly growing Work Number records, now at 217 million active records with 108 million unique Social Security numbers, along with high margin Workforce Solutions revenue and 52.1% segment EBITDA margins, are increasing the share of recurring verification income and supporting group level margin expansion.
See why 30 investors see Equifax as 31% undervalued.
Result: Fair Value of $214.95 (UNDERVALUED)
Still, the Equifax narrative leans heavily on government verification and mortgage credit structures, where delayed contract ramp and changing bureau requirements could pressure earnings assumptions.
Find out about the key risks to this Equifax narrative.
Next Steps
Sentiment around Equifax is split, with both concerns and bright spots on the table. Move quickly, review the detail, and weigh the 4 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Equifax?
If Equifax has you reassessing where your money works hardest, use this moment to widen your watchlist and pressure test your next moves.
- Target dependable income streams by scanning companies that show up in the 7 dividend fortresses and weigh their payouts against your own cash flow needs.
- Hunt for mispriced opportunities by checking the 30 high quality undervalued stocks and compare their valuations with what you are seeing in your current holdings.
- Strengthen your downside protection by reviewing the list of solid balance sheet and fundamentals (24 results) before the next bout of volatility catches you off guard.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com